UK Bans Parallel Export Of 24 Drugs As Brexit Nears
The move should help protect industry’s no-deal stockpiles
Executive Summary
The UK government has drawn up a list of 24 medicines that must not be parallel exported to EU countries. The move is widely seen as a way of protecting stockpiles of drugs that have been built up to compensate for supply chain problems in the event of a no-deal Brexit.